Page 2 - Debbie Etchison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article JERSEY CITY, N.J., May 12, 2021 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced it will present findings from a new analysis of claims data from a cohort of patients who received RADICAVA ® (edaravone) for the treatment of amyotrophic lateral sclerosis (ALS). The analysis will be presented during the 2021 European Network to Cure ALS (ENCALS) Meeting, being held virtually May 12-14. "Initial insights shared with the scientific community during ENCALS are a part of our wide-ranging efforts to compile real-world data that ca...

Share this article Share this article JERSEY CITY, N.J., April 20, 2021 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of an analysis of the timing of disease progression milestones among commercially insured amyotrophic lateral sclerosis (ALS) patients treated with intravenous (IV) RADICAVA ® (edaravone). The findings are being presented during the 2021 Virtual American Academy of Neurology (AAN) Annual Meeting, held April 17-22. "We are pleased to share these data, which may provide information to the ALS community by observing the time to r...

Mitsubishi Tanabe Pharma America Presents Data on Impact of ALS Symptoms on Patients' Ability to Independently Conduct Daily Activities Analysis Shared at 2021 Muscular Dystrophy Association Annual Clinical & Scientific Conference News provided by Share this article Share this article JERSEY CITY, N.J., March 17, 2021 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced findings from a new analysis evaluating the impact of symptom progression on the ability of people with amyotrophic lateral sclerosis (ALS) to independently conduct activities of daily living (ADLs). ...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Mitsubishi Tanabe Pharma America Celebrates Five Years of Dedication to the ALS Community in the U.S. February 8, 2021 GMT MTPA Logo (PRNewsfoto/Mitsubishi Tanabe Pharma Americ) JERSEY CITY, N.J., Feb. 8, 2021 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today celebrated its five-year anniversary of being established in the United States in 2016. MTPA has followed an unwavering patient-first philosophy focused on advancing innovative treatments for people facing serious and life-threat...

Share this article Share this article JERSEY CITY, N.J., Jan. 14, 2021 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced upgrades to its out-of-pocket assistance program that aim to provide enhanced support for eligible patients with amyotrophic lateral sclerosis (ALS) treated with RADICAVA ® (edaravone) through more efficient communication and exchange of information, including a new "hybrid" card that can be used to help access appropriate pharmacy and medical co-pay assistance.   "Our modified 'all-in-one' out-of-pocket assistance program was designed with o...